Who Paid My Doc
UC P3: Double-Blind Treat Straight Through
Research payments
$5,704,720
Through program year 2025, $5,704,720 in research payments was reported against UC P3: Double-Blind Treat Straight Through, across 911 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $5,097,906 | 895 |
| 2024 | Research | $606,814 | 16 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Niaz Ausaf Lakeland, FL Named on 69 payments
- Ryan Gaible Columbus, OH Named on 62 payments
- Ziad Younes Southaven, MS Named on 60 payments
- George Duvall Tyler, TX Named on 49 payments
- Roy Peters Cody, WY Named on 35 payments
- Humberto Aguilar Fort Worth, TX Named on 33 payments
- Mousab Tabbaa Westlake, OH Named on 26 payments
- Manuel Rodriguez Lakewood Ranch, FL Named on 21 payments
- Bixuan Lin Chicago, IL Named on 20 payments
- Jeff Bullock San Antonio, TX Named on 19 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.